Anupam Rasayan India Ltd
Anupam Rasayan India Ltd (ANURAS) last reported results for the quarter ended Jun 2026, with sales of ₹655 crore and net profit of ₹51 crore. The stock last traded at ₹1,176, a market capitalisation of ₹13,385 crore, on a P/E of 76.6. Over the past 52 weeks the stock has ranged between ₹1,047 and ₹1,415. Figures are as of 6 Oct 2026 and are not real time.
Anupam Rasayan India Ltd share price and key metrics
- Current price
- ₹1,176
- Market cap
- ₹13,385 cr
- Stock P/E
- 76.6
- Book value
- ₹290
- ROE
- 5.55%
- ROCE
- 7.38%
- Dividend yield
- 0.13%
- 52w high / low
- 1415/1047
Metrics as of 6 Oct 2026. Not real time.
Track Anupam Rasayan India Ltd
Cruxal reads every Anupam Rasayan India Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Anupam Rasayan India Ltd growth and returns
- 10 Years
- %
- 5 Years
- 24%
- 3 Years
- 14%
- TTM
- 52%
- 10 Years
- %
- 5 Years
- 19%
- 3 Years
- -2%
- TTM
- 42%
- 10 Years
- %
- 5 Years
- 8%
- 3 Years
- 9%
- 1 Year
- 8%
- 10 Years
- %
- 5 Years
- 6%
- 3 Years
- 5%
- Last Year
- 6%
Anupam Rasayan India Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹655 cr, up 34.8% from ₹486 cr a year earlier. Net profit was ₹51 cr, up 6.3% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 294 | 390 | 500 | 486 | 731 | 512 | 636 | 655 |
| Expenses | 214 | 266 | 356 | 362 | 596 | 385 | 498 | 493 |
| Operating profit | 80 | 124 | 144 | 124 | 136 | 127 | 137 | 162 |
| OPM % | 27% | 32% | 29% | 26% | 19% | 25% | 22% | 25% |
| Other income | 2 | -4 | 6 | 5 | 8 | 2 | 3 | 13 |
| Interest | 27 | 32 | 31 | 36 | 36 | 35 | 42 | 49 |
| Depreciation | 22 | 29 | 31 | 31 | 32 | 34 | 43 | 56 |
| Profit before tax | 34 | 59 | 88 | 63 | 76 | 60 | 56 | 70 |
| Tax % | 10% | 9% | 29% | 23% | 24% | -1% | 0% | 27% |
| Net profit | 31 | 54 | 63 | 48 | 57 | 61 | 56 | 51 |
| EPS (₹) | 1.52 | 2.56 | 4.05 | 3.10 | 3.90 | 4.31 | 3.75 | 3.39 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Anupam Rasayan India Ltd annual results
| ₹ crore | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 502 | 529 | 811 | 1,074 | 1,602 | 1,475 | 1,437 | 2,365 | 2,535 |
| Operating profit | 93 | 135 | 194 | 305 | 431 | 381 | 401 | 526 | 563 |
| OPM % | 19% | 25% | 24% | 28% | 27% | 26% | 28% | 22% | 22% |
| Net profit | 49 | 53 | 70 | 152 | 217 | 167 | 160 | 222 | 225 |
| EPS (₹) | 9.85 | 10.64 | 7.04 | 15.18 | 16.83 | 11.71 | 8.49 | 14.94 | 15.35 |
TTM is the trailing twelve months to the most recent quarter.
Anupam Rasayan India Ltd balance sheet
| ₹ crore | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 50 | 50 | 100 | 100 | 107 | 110 | 110 | 114 |
| Reserves | 432 | 515 | 1,473 | 1,627 | 2,265 | 2,651 | 2,740 | 3,188 |
| Borrowings | 694 | 847 | 423 | 836 | 822 | 1,069 | 1,373 | 1,867 |
| Other liabilities | 146 | 252 | 301 | 327 | 584 | 772 | 1,045 | 2,843 |
| Total liabilities | 1,323 | 1,664 | 2,298 | 2,891 | 3,778 | 4,602 | 5,269 | 8,013 |
| Fixed assets | 681 | 977 | 1,115 | 1,202 | 1,417 | 1,501 | 2,185 | 3,713 |
| CWIP | 191 | 101 | 43 | 44 | 120 | 609 | 216 | 114 |
| Investments | 0 | 0 | 0 | 149 | 67 | 67 | 9 | 19 |
| Other assets | 451 | 586 | 1,140 | 1,496 | 2,173 | 2,424 | 2,860 | 4,167 |
| Total assets | 1,323 | 1,664 | 2,298 | 2,891 | 3,778 | 4,602 | 5,269 | 8,013 |
As reported by the company. Total assets equal total liabilities by construction.
Anupam Rasayan India Ltd cash flow
| ₹ crore | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 39 | 95 | 1 | -171 | 292 | 59 | -30 | 334 |
| Cash from investing | -250 | -178 | -193 | -412 | -523 | -392 | -330 | -820 |
| Cash from financing | 206 | 102 | 416 | 384 | 371 | 395 | 223 | 621 |
| Net cash flow | -6 | 19 | 224 | -199 | 140 | 62 | -137 | 135 |
| Free cash flow | -209 | -85 | -144 | -318 | 232 | -644 | -440 | -220 |
| CFO / operating profit | 55% | 77% | 10% | -44% | 84% | 28% | 3% | 72% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Anupam Rasayan India Ltd operating ratios
| Per year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | — | 9% | 10% | 11% | 13% | 9% | 7% | 7% |
| Debtor days | 88 | 89 | 92 | 95 | 95 | 143 | 186 | 148 |
| Inventory days | 277 | 515 | 530 | 852 | 483 | 627 | 876 | 490 |
| Days payable | 105 | 226 | 215 | 225 | 167 | 247 | 348 | 261 |
| Cash conversion cycle | 260 | 379 | 408 | 722 | 410 | 524 | 715 | 377 |
| Working capital days | 56 | 21 | 168 | 218 | 153 | 138 | 160 | 108 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Anupam Rasayan India Ltd shareholding pattern
Promoters held 59.07% at Jun 2026, down from 61.19% at Jun 2025. FIIs 7.72% and DIIs 0.38%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 61.23% | 61.19% | 61.19% | 61.19% | 59.07% | 59.07% | 59.07% | 59.07% |
| FIIs | 7.00% | 7.46% | 6.47% | 4.94% | 7.63% | 7.60% | 6.91% | 7.72% |
| DIIs | 2.30% | 2.32% | 2.25% | 2.24% | 1.37% | 0.41% | 0.35% | 0.38% |
| Public | 29.47% | 29.06% | 30.11% | 31.65% | 31.93% | 32.89% | 33.65% | 32.82% |
| No. of shareholders | 63,866 | 60,938 | 57,478 | 47,711 | 48,785 | 47,469 | 43,475 | 42,776 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Anupam Rasayan India Ltd corporate filings
- SEBI disclosure reveals pledge of 17.07% of Anupam Rasayan India Limited's equity shares by Catalyst Trusteeship Limited, indicating potential collateral backing for debt obligationsInsider Trading / SASTmedium impact
Cruxal's analysis: Anupam Rasayan India Limited's shares worth approximately INR 1,94,29,000 (17.07% of…
Read the full analysis - Confirmation of Non-Applicability of Regulation 74(5) of SEBI DP Regulations, for the quarter ended September 30, 2026.Company Updatelow impact
- SEBI disclosure of promoter encumbrance for Mona Anandbhai Desai received on October 6, 2026Insider Trading / SASTlow impact
Cruxal's analysis: The exchange has received a disclosure regarding the reasons for encumbrance by Mona…
Read the full analysis - SEBI disclosure reveals pledge release of 41.4 lakh shares by promoter Mona Anandbhai Desai of Anupam Rasayan India Limited, reducing encumbered shares from 3.64% to 1.28% of total share capitalInsider Trading / SASThigh impact
Cruxal's analysis: Anupam Rasayan India Limited's promoter Mona Anandbhai Desai has released a total of 41.4…
Read the full analysis - SEBI disclosure reveals pledge of 14.90% of Anupam Rasayan India Limited shares by Catalyst Trusteeship Limited, indicating potential collateralization of significant shareholdingInsider Trading / SASTmedium impact
Cruxal's analysis: Anupam Rasayan India Limited's shares representing 14.90% of its total equity…
Read the full analysis - Rehash Industrial and Resins Chemicals Private Limited releases pledge on 50 lakh shares of Anupam Rasayan India Limited, indicating a significant corporate action related to share encumbrance.Insider Trading / SASTmedium impact
Cruxal's analysis: Rehash Industrial and Resins Chemicals Private Limited, a promoter of Anupam Rasayan…
Read the full analysis - Promoter Mona Anandbhai Desai creates pledge on 14.6 lakh shares of Anupam Rasayan India Limited, indicating potential collateral or strategic moveInsider Trading / SASTmedium impact
Cruxal's analysis: Mona Anandbhai Desai, a promoter of Anupam Rasayan India Limited, has created a pledge on…
Read the full analysis - Promoter pledge creation involving 1.10 crore shares (~9.73%) of Anupam Rasayan India Limited indicates significant collateralization, potentially signaling liquidity management or strategic financial structuring.Insider Trading / SASTmedium impact
Cruxal's analysis: Anupam Rasayan India Limited's promoters Anand Sureshbhai Desai and Shraddha Anand Desai…
Read the full analysis - Anupam Rasayan India Ltd. Passes Key Resolutions with Over 99.99% Voting Support in 23rd AGMAGM/EGMhigh impact
Cruxal's analysis: Anupam Rasayan India Ltd. conducted its 23rd AGM on September 30, 2026, with resolutions…
Read the full analysis - Anupam Rasayan India Ltd. completes acquisition of 47.95% stake in Bliss GVS Pharma Limited for approximately INR 509.84 crore, clarifying previous typographical errors in disclosureCompany Updatehigh impact
Cruxal's analysis: Anupam Rasayan India Ltd. has finalized the acquisition of 47.95% equity shares of Bliss…
Read the full analysis - Anupam Rasayan India Limited discloses pledge release of 33.4 lakh shares held by promoter Anand Sureshbhai Desai, following partial redemption of NCDs worth INR 160 crore, indicating a strategic deleveraging move.Insider Trading / SASThigh impact
Cruxal's analysis: Anupam Rasayan India Limited's promoter Anand Sureshbhai Desai has released a pledge on…
Read the full analysis - Anupam Rasayan India Limited holds its 23rd AGM on September 30, 2026, with key resolutions including dividend declaration, reappointment of director, and ratification of cost auditor's remuneration, amidst a comprehensive virtual participation setup.AGM/EGMlow impact
Cruxal's analysis: Anupam Rasayan India Limited conducted its 23rd AGM via video conferencing, with 38…
Read the full analysis - Anupam Rasayan India Limited pledges 103.62 lakh equity shares to Catalyst Trusteeship Limited, representing 9.10% of total share capital, via a pledge agreement dated September 23-25, 2026.Insider Trading / SASTmedium impact
Cruxal's analysis: Anupam Rasayan India Limited has disclosed a pledge of 1.036 crore equity shares (valued…
Read the full analysis - The trading window of the Company for dealing in the securities shall remain closed from Thursday, 01 October 2026 till the end of the 48 hours after declaration of unaudited Financial ....Insider Trading / SASTlow impact
- Anupam Rasayan Completes Strategic Acquisition of 48.2% Stake in Bliss GVS Pharma to Build Integrated Global PlatformCompany Updatehigh impact
Cruxal's analysis: Anupam Rasayan India Ltd. has successfully concluded the acquisition of a 48.2%…
Read the full analysis - Anupam Rasayan India Ltd announces allotment of Non-Convertible DebenturesCompany Updatelow impact
Cruxal's analysis: Anupam Rasayan India Ltd has completed the allotment of Non-Convertible Debentures (NCDs)…
Read the full analysis - Anupam Rasayan India Ltd approves issuance of Non-Convertible Debentures on private placement basisCompany Updatemedium impact
Cruxal's analysis: The Board of Directors of Anupam Rasayan India Ltd approved the issuance of…
Read the full analysis - Anupam Rasayan India Ltd. Approves Private Placement of INR 160 Crore Secured Non-Convertible DebenturesBoard Meetingmedium impact
Cruxal's analysis: Anupam Rasayan India Ltd. has announced the issuance of secured, rated, unlisted…
Read the full analysis - Anupam Rasayan India Limited Approves Corporate Guarantees and Share Pledges for Subsidiary Financing and Strategic Call OptionOthersmedium impact
Cruxal's analysis: Anupam Rasayan India Limited has approved the issuance of up to 300 crore in senior…
Read the full analysis - Anupam Rasayan India Ltd. to consider INR 160 crore fund raising via NCDsBoard Meetingmedium impact
Cruxal's analysis: Anupam Rasayan India Ltd. has announced a board meeting scheduled for September 19, 2026…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.